Manuel Patino Galindo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Dual-Energy Scanned Projection | 5 | 2018 | 204 | 1.180 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2018 | 1226 | 0.970 |
Why?
|
Radiography, Abdominal | 3 | 2018 | 541 | 0.950 |
Why?
|
Iodine | 4 | 2018 | 286 | 0.700 |
Why?
|
Tomography, X-Ray Computed | 11 | 2018 | 20765 | 0.670 |
Why?
|
Contrast Media | 7 | 2018 | 5336 | 0.660 |
Why?
|
Barium Sulfate | 1 | 2017 | 180 | 0.550 |
Why?
|
Pancreatic Ducts | 1 | 2017 | 330 | 0.500 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 196 | 0.480 |
Why?
|
Pancreatic Cyst | 1 | 2017 | 369 | 0.430 |
Why?
|
Pancreatic Neoplasms | 4 | 2018 | 5443 | 0.420 |
Why?
|
Radiation Protection | 1 | 2015 | 428 | 0.380 |
Why?
|
Radiation Dosage | 2 | 2016 | 1974 | 0.340 |
Why?
|
Spleen | 1 | 2016 | 2296 | 0.330 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2017 | 1755 | 0.330 |
Why?
|
Pancreas | 1 | 2016 | 1702 | 0.310 |
Why?
|
Liver Neoplasms | 3 | 2018 | 4365 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2846 | 0.290 |
Why?
|
Artifacts | 1 | 2015 | 1930 | 0.260 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2336 | 0.260 |
Why?
|
Liver | 3 | 2018 | 7574 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2017 | 3627 | 0.230 |
Why?
|
Phantoms, Imaging | 3 | 2018 | 2528 | 0.220 |
Why?
|
Pancreatectomy | 2 | 2018 | 824 | 0.220 |
Why?
|
Radiographic Image Enhancement | 2 | 2018 | 877 | 0.210 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6406 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9433 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 9063 | 0.150 |
Why?
|
Iopamidol | 1 | 2018 | 187 | 0.140 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 353 | 0.130 |
Why?
|
Portal Vein | 1 | 2016 | 432 | 0.110 |
Why?
|
Subtraction Technique | 1 | 2016 | 519 | 0.110 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11254 | 0.110 |
Why?
|
Hospitals, General | 1 | 2017 | 807 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2018 | 81801 | 0.090 |
Why?
|
Angiography | 1 | 2016 | 1598 | 0.090 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59686 | 0.090 |
Why?
|
Administration, Oral | 1 | 2017 | 4039 | 0.080 |
Why?
|
Body Composition | 1 | 2018 | 2461 | 0.080 |
Why?
|
Forecasting | 1 | 2017 | 2948 | 0.080 |
Why?
|
Aged | 8 | 2018 | 171562 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1317 | 0.070 |
Why?
|
Algorithms | 3 | 2016 | 14154 | 0.070 |
Why?
|
Middle Aged | 8 | 2018 | 223491 | 0.070 |
Why?
|
Humans | 15 | 2018 | 768393 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9371 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1959 | 0.060 |
Why?
|
Male | 9 | 2018 | 364902 | 0.050 |
Why?
|
Adult | 6 | 2018 | 223640 | 0.050 |
Why?
|
Female | 8 | 2018 | 397089 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14737 | 0.050 |
Why?
|
Prognosis | 2 | 2018 | 30022 | 0.040 |
Why?
|
Incidence | 1 | 2017 | 21544 | 0.040 |
Why?
|
Risk Assessment | 1 | 2017 | 24318 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40272 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13697 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1343 | 0.030 |
Why?
|
Abdomen | 1 | 2018 | 1136 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 65379 | 0.020 |
Why?
|
Young Adult | 1 | 2017 | 60049 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 74962 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36849 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3529 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20224 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2909 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8562 | 0.020 |
Why?
|
Software | 1 | 2016 | 4453 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 13020 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15939 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39407 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54920 | 0.010 |
Why?
|